Atlas Trials

Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study

Clinical trial NCT05109585 · UNKNOWN

Trial details

NCT number
NCT05109585
Sponsor
Collegium Medicum w Bydgoszczy
Status
UNKNOWN
Study type
OBSERVATIONAL
SARS-CoV2 InfectionSARS-CoV2 Antibodies
Start date
2021-04-20
Primary completion
2022-10-12
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.